submitted / IN PREPARATION
Inkster B et al. commissioned by The Lancet Psychiatry to write a Series of papers on topics including digital psychiatry, artificial intelligence and ethics. In prep for submission for late 2018.
Shepard M, Inkster B. Ultra-audible sound perception and watermarking wellbeing. Under consideration. Nature Biotechnology, 2018.
Inkster B, Sarda S, Subramanian V. A mixed methods real-world data evaluation of a smartphone-based empathy-focused conversational agent to support mental wellness. Under consideration, Journal of Medical Internet Research, 2018.
Inkster B, Guest Editor: AI & Society: Journal of Knowledge, Culture and Communication. Special Issue entitled: “Trust: promise and hype of digital mental health innovation”. A collection of papers will be released 2018-2019 based on conference proceedings from Digital Innovation in Mental Health, 17-18th July, 2018.
Inkster B, Meshi D, Nicodemus K, Kosinski M, Stillwell D. Why geneticists should leverage social media data. In prep for submission to Nature Genetics, 2018.
PUBLISHED / ACCEPTED
Doukani A,Wei X, Kader B, Soazandry F, Inkster B. Views from the street pilot study: Constraints and difficulties of using photographs in research of a complex nature such as homelessness. Accepted. Biomedical Informatics Insights, 2018.
Russ TC, Woelbert E, Davis KAS, Hafferty J, Ibrahim Z, Inkster B, John A, Lee W, Maxwell M, McIntosh AM, Stewart R; for the MQ Data Science Group. Data science and mental health: definitions, implications, and applications. Accepted. Nature Human Behaviour, 2018.
Inkster B, Zai G, Lewis G, Miskowiak KW. GSK3beta: a plausible mechanism of cognitive and hippocampal change induced by erythropoietin treatment in mood disorders? Review. Accepted. Translational Psychiatry. 2018.
Inkster B, Simmons A, Cole J, Schoof E, Linding R, Sämann PG, Holsboer F, Matthews PM, Lewis C, McGuffin P, Nicodemus K. Unravelling the GSK3beta-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder. Accepted. Psychiatric Genetics, 2018.
Inkster B, Guest Editor: Biomedical Informatics Insights. Editorial: Proceedings from the Digital Innovation in Mental Health Conference, London, 2017. This editorial is part of a Special Collection released in 2018 for a conference I created and lead on called Digital Innovation in Mental Health.
Sule A, Inkster B. Eminem's character, Stan: a bio-psycho-social autopsy. Journal of Hip Hop Studies, 2017; 4(1): 43–49.
Kiddle, B, Inkster, B, Prabhu, G, Moutoussis, M, Whitaker, K, Bullmore, E, et al. The NSPN 2400 Cohort: a developmental sample supporting the Wellcome Trust Neuroscience in Psychiatry Network. International Journal of Epidemiology, 2017; 47(1): 18-19.
Inkster B, Stillwell D, Kosinski M, Jones PB. A decade into Facebook: where is psychiatry in the digital age? The Lancet Psychiatry, 2016; 3(11): 1087-1090.
Whitaker KJ, Vertes PE, Romero-Garcia R, Vasa F, Moutoussis M, Prabhu G, Weisskopf N, Callaghan MF, Wagstyl K, Rittman T, Tait R, Ooi C, Suckling J, Inkster B, Fonagy P, Dolan RJ, Jones PB, Goodyer IM, Bullmore ET. Adolescence is associated with transcriptionally patterned consolidation of the hubs of the human brain connector. PNAS, 2016; 113(32): 9105-9110.
Miskowiak KW, Vinberg M, Macaveanu J, Ehrenreich H, Køster N, Inkster B, Paulson OB, Kessing LV, Skimminge A, Siebner HR. Effects of erythropoietin on hippocampal volume and memory in mood disorders. Biol Psychiatry. 2015; 78(4): 270–7.
Sule A, Inkster B. Kendrick Lamar: street poet of mental health. The Lancet Psychiatry. 2015; 2(6): 496–7.
Inkster B, Sule A. Drug term trends in American hip-hop lyrics. J Public Mental Health. 2015; 14(3): 169–73.
Toseeb U, Inkster B. Online social networking sites and mental health research. Frontiers in Psychiatry. 2015; 6(36). 1–4.
Sule A, Inkster B. A hip-hop state of mind. The Lancet Psychiatry. 2014; 1(7): 494–495.
Weiskopf N, Suckling S, Williams G, Morgado Correia M, Inkster B, Tait R, Ooi C, Bullmore ET, Lutti A. Quantitative multi-parameter mapping of R1, PD*, MT and R2* at 3T: a multi-center validation. Front. Neurosci. Brain Imaging Methods. 2013; 7(95): 1–11.
Inkster B, Vounou M, Montana G, ADNI Consortium. Genetic screening of the human kinome identifies a cellular signalling network predictive of brain atrophy in Alzheimer’s disease. Conference poster, British Association of Psychopharmacology, 2017.
Inkster B, Strijbis EM, Vounou M, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ. Histone deacetylase gene variants predict brain volume changes in multiple sclerosis. Neurobiol. Aging. 2013; 34(1): 238–247.
Strijbis EM*, Inkster B*, Vounou M, Naegelin Y, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ. Glutamate gene polymorphisms predict brain volumes in multiple sclerosis. Mult. Scler. 2013; 19(3): 281–288.
Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ. GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci. Biobehav. Rev. 2012; 36(9): 2044–2055.
Inkster B, Rao A, Ridler K, Filippini N, Whitcher B, Nichols T, Wetten S, Gibson R, Borrie M, Kertesz A, Guzman D, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM. GOLM1 genetic variation associations with prefrontal cortex morphology and Alzheimer’s disease risk. Neurobiol Aging. 2012; 33(3): 457–465.
Dixson L, Ridler K, Nichols T, Saemann P, Auer D, Holsboer F, Muglia P, Matthews PM, Inkster B. Thyroid transporter gene polymorphisms and brain structural differences in healthy controls and patients with major depressive disorder. Psychoneuroendocrinology. 2011; 36(6): 929–934.
Inkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Tozzi F, Merlo-Pich E, Muglia P, Matthews PM. Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J. Neuroimaging. 2011; 21(4): 375–382.
Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM. Pathway-based approaches to imaging genetics association studies: wnt signaling, GSK3beta substrates and major depression. Neuroimage: Special Issue on Imaging Genetics. 2010; 53(3): 908–917.
Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ. Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients. Psychopharmacology. 2010; 210(3): 419–428.
Inkster B, Nichols T, Saemann P, Auer D, Holsboer F, Muglia P, Matthews P. Association of GSK3B polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry. 2009; 66(7): 721–728.
Miskowiak K, Favaron E, Hafizi S, Inkster B, Goodwin G, Cowen P, Harmer C. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology 2009; 207(1): 133–142.
Mannie Z, Norbury R, Murphy SE, Inkster B, Harmer CJ, Cowen PJ. Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression. Br J Psychiatry. 2008; 192(5): 356–361.
Miskowiak K, Inkster B, O’Sullivan U, Selvaraj S, Goodwin GM, Harmer CJ. Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration. Exp Brain Res. 2008; 184(3): 313–321.
Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ. Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology. 2008; 33(3): 611–618.
Miskowiak K, Inkster B, Selvaraj S, Goodwin GM, Harmer CJ. Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration. Psychopharmacology. 2007; 195(3): 451–453.
Inkster B, Muglia P, Jain U, Kennedy JL. Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder. Psychiatr Genet. 2004; 14(2): 117–120.
Muglia P, Jain U, Inkster B, Kennedy JL. A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD. Neuropsychopharmacology 2002; 27(4): 655–662.